Brian Barry, now Emeritus Professor, was Professor of Pharmaceutical Technology and Head of the Drug Delivery Group of The School of Pharmacy, Head of Pharmacy and Dean of Life Sciences, University of Bradford, UK.
His education includes a BSc (Pharmacy) and a DSc (University of Manchester) together with a PhD from the Faculty of Medicine of the University of London. He is a Fellow of the Royal Pharmaceutical Society of Great Britain, and formally a Chartered Chemist, a Fellow of the Royal Society of Chemistry and a Fellow of the American Association of Pharmaceutical Scientists and is a recipient of a British Pharmaceutical Conference Science Award.
His previous experience includes employment as a community pharmacist and in the pharmaceutical industry and as an academic at London, Portsmouth and Bradford Universities.
His main research interests are in colloid science and drug delivery systems, especially via the topical and transdermal routes, with over 400 research publications. He has a wide and varied experience of collaborating with some forty firms in the pharmaceutical industry in the UK, Europe, USA and Australia. He has served as a member of the Chemistry, Pharmacy and Standards Sub-Committee of the Committee on Safety of Medicines and advised the Medicines Control Agency of the UK and the Food and Drug Administration of the USA on topical and transdermal delivery of drugs.
Among others, he has refereed for the Science and Engineering Research Council, Medical Research Council, BBSRC, Wellcome Foundation, NATO, and South African, Israeli and Spanish Governments.